Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from Prevotella
A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel diseasecomprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strains selected from the group consisting of Prevotella copri, Prevotella stercorea,Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.Prevotellaceae türlerinden en az bir izole edilmiş bakteri suşunu içeren obezite, metabolik sendrom, tip 2 diyabet, kardiyovasküler hastalıklar, demans, alzheimer hastalığı ve enflamatuvar bağırsak hastalığının tedavisinde kullanılan bir ürün olup, burada suş, Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A ve Prevotella distasonis'ten oluşan gruptan seçilir.Ürün bir gıda ürünü olabilir.
